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Abstract
Background: Endosomal small GTPases of the Rab family, among them Rab4a, play an essential role in the control of the
glucose transporter GLUT4 trafficking, which is essential for insulin-mediated glucose uptake. We found that adipocytes also
expressed Rab4b and we observed a consistent decrease in the expression of Rab4b mRNA in human and mice adipose
tissue in obese diabetic states. These results led us to study this poorly characterized Rab member and its potential role in
glucose transport.
Methodology/Principal Findings: We used 3T3-L1 adipocytes to study by imaging approaches the localization of Rab4b
and to determine the consequence of its down regulation on glucose uptake and endogenous GLUT4 location. We found
that Rab4b was localized in endosomal structures in preadipocytes whereas in adipocytes it was localized in GLUT4 and in
VAMP2-positive compartments, and also in endosomal compartments containing the transferrin receptor (TfR). When Rab4b
expression was decreased with specific siRNAs by two fold, an extent similar to its decrease in obese diabetic subjects, we
observed a small increase (25%) in basal deoxyglucose uptake and a more sustained increase (40%) in presence of
submaximal and maximal insulin concentrations. This increase occurred without any change in GLUT4 and GLUT1
expression levels and in the insulin signaling pathways. Concomitantly, GLUT4 but not TfR amounts were increased at the
plasma membrane of basal and insulin-stimulated adipocytes. GLUT4 seemed to be targeted towards its non-endosomal
sequestration compartment.
Conclusion/Significance: Taken our results together, we conclude that Rab4b is a new important player in the control of
GLUT4 trafficking in adipocytes and speculate that difference in its expression in obese diabetic states could act as a
compensatory effect to minimize the glucose transport defect in their adipocytes.
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Introduction
Glucose transporter 4 (GLUT4) plays an important role in
glucose homeostasis. It is mainly expressed in cells that exhibit
insulin-regulated glucose uptake, i.e adipocytes, skeletal muscle
cells and cardiomyocytes. The intracellular trafficking of GLUT4
is a major determinant of the acute regulation of glucose transport
in these cells. In basal state, GLUT4 is present in intracellular
locations, referred to as the sequestration compartments, from
which it undergoes insulin dependent movement to the plasma
membrane [1]. In type 2 diabetic patients, alterations in GLUT4
translocation arise from defects in insulin signalling and in
GLUT4 expression [2]. Furthermore, GLUT4 appears mis-
located in muscles and adipocytes of diabetic patients [3,4] or in
omental adipocytes of women with gestational diabetes, even when
its expression remains normal [5]. Hence, the machinery that
regulates GLUT4 trafficking could be altered in insulin-responsive
cells of diabetic patients. Understanding the molecular mecha-
nisms controlling GLUT4 trafficking and their alteration in
insulin-resistant situations thus represents a major issue for
understanding this pathology.
Small GTPases of the Rab family are main organizers of
intracellular trafficking [6]. Several Rab members have been
involved in GLUT4 trafficking [7,8,9]. In particular three Rab
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5257proteins of the endosomal recycling system, Rab5, Rab4, and
Rab11 participate at different steps of this process
[10,11,12,13,14]. Rab8, Rab10 and Rab14, the putative targets
of AS160 [15], a RabGAP inactivated by the insulin-induced PKB
pathway [16], were also suspected to play a role in GLUT4
recycling. However Rab8 and Rab14 would act in muscle cells
[17] whereas Rab10 would be more important in adipocytes [16].
Rab31, a Rab5 family member, participates in insulin-induced
GLUT4 translocation to the plasma membrane. Insulin delocal-
izes its exchanger Gapex-5 to the plasma membrane and inhibits
Rab31 activity, thus potentiating insulin-induced GLUT4 trans-
location [18].
In the present study, we first aimed at determining whether the
expression of Rab proteins of the endocytic recycling pathway was
modified in adipose tissues from obese diabetic subjects. We found
that Rab4b expression was modified in adipose tissues from both
diabetic obese human and mice. It has already been proposed that
Rab4a, that possesses 93% of homology with Rab4b, could play a
role in GLUT4 trafficking [12,19,20,21], at least in part through
its interaction with the Rab4a effector Rabip4 [22] and with the
kinesin KIF3B [11]. The role of Rab4b is unknown and we thus
aimed at determining whether Rab4b could be involved in the
control of GLUT4 localization and glucose transport in adipo-
cytes. First, we showed that Rab4b is mainly located with GLUT4,
in its sequestration compartment and in TfR containing
endosomes. Rab4b is thus the first Rab protein identified in the
GLUT4-sequestration compartment. Second, using different
approaches we showed that the inhibition of Rab4b expression
resulted in GLUT4 localization changes, with an equilibrium
redistribution towards the plasma membranes and probably its
sequestration compartments. We thus postulate that Rab4b could
be involved in GLUT4 trafficking cycles that allow for GLUT4
intracellular retention in basal conditions.
Results
Modifications of some Rabs of the endocytic recycling
pathway in diabetes
Because defects in GLUT4 trafficking could participate in
insulin-resistance [3,4], we determined whether the expression of
Rabs involved in endocytic recycling was modified in adipose
tissues from obese diabetic mice and humans. Figure 1A shows
that the expression of Rab4a and Rab4b mRNAs, and IRS1
mRNA used as a control, was significantly decreased in the
epididymal adipose tissues from the obese diabetic db/db animals,
compared to their lean control (db/+) mice. The mRNA
expression for Rab5a, Rab11a and Rab14 was unchanged
(Figure 1A), as well as those for Rab8a and Rab10 (data not
shown). By using an antibody recognizing all Rab4 proteins, we
observed a significant decrease in their expression in db/db
compared to lean db/+ animals, whereas Rab11 expression was
not statistically different (figure 1B). The expression of GLUT4 at
the protein level was profoundly decreased in db/db mice adipose
tissue, although the differences at the mRNA level were not
significant. Rab4b mRNA expression was also significantly
decreased in subcutaneous adipose tissue from morbidly obese
diabetic patients compared to lean subjects (Figure 1C). Rab4a
mRNA expression was decreased to a lesser extent, and the
difference did not reach statistical significance. In these morbidly
obese diabetic patients, the mRNA for Rab5a and Rab11a were
increased whereas that of Rab14 was unchanged. The modified
expression of the endosomal Rab proteins, especially the inhibition
of expression of Rab4b, could thus contribute to the altered
functions of adipose tissue in obese diabetic subjects.
Rab4b mRNA is the predominant Rab4 member in
adipocytes
Because the expression of Rab4 members was modified in total
adipose tissues in diabetic state, we further wanted to determine
whether these two proteins were expressed in the adipocytes
themselves. By Northern Blot analysis, we evidenced the mRNA
for Rab4a and Rab4b in freshly isolated and in cultured (3T3-L1)
mouse adipocytes (Figure 2A). Rab4a and Rab4b are indeed
ubiquitous and we also found their mRNA in lung and heart. By
real time PCR, we found that Rab4b mRNA was more abundant
than that for Rab4a in 3T3-L1 adipocytes and in human
adipocytes differentiated in culture from visceral preadipocytes
(Figure 2B). Both Rab4a and Rab4b mRNAs increased during the
differentiation of mouse (3T3-L1) and human preadipocytes into
adipocytes (Figure 2C). This observation is in accordance with the
increased Rab4 proteins we previously reported in 3T3-L1
adipocytes compared to fibroblasts [23]. Thus, Rab4b mRNA is
the predominant Rab4 mRNA in adipocytes.
Expressed Rab4a and Rab4b are co-localized in 3T3-L1
fibroblasts but not in adipocytes
We next wanted to compare Rab4b and Rab4a localization in
adipocyteinordertodeterminewhethertheypotentiallycouldfulfill
different functions. The characterization of the two Rab4s at the
protein level requires specific antibodies. Because available
monoclonal and polyclonal antibodies despite they were supposed
to be specific for Rab4a also recognized Rab4b in Western Blot
(Figure 2D), we developed antibodies against the C terminal specific
part of Rab4b. The obtained antiserum recognized overexpressed
Rab4b but not Rab4a (Figure 2E), but unfortunately, none of those
antibodies detected endogenous levels of Rab4 proteins in indirect
immunofluorescence. We thus compared the localization of
expressed Rab4b and Rab4a fused to different tags in 3T3-L1
cells. Hemagglutinin (HA)-Rab4b and myc-Rab4a were mostly
present and colocalized in the perinuclear region of 3T3-L1
fibroblasts (Figure 3). Interestingly, when expressed in adipocytes,
HA-Rab4b and myc-Rab4a were mainly associated with different
vesicles dispersed into the cytoplasm, whereas a partial colocaliza-
tion was detected in the perinuclear region (Figure 3). This
observation suggests that Rab4b, when adipocyte differentiation
occurs, is partly segregated from the early endosomes, which are
labeled by Rab4a in many cell types [24,25].
Rab4b is largely colocalized with GLUT4 or VAMP2 and to
a lower extent with the transferrin receptor in 3T3-L1
adipocytes
We next aimed at determining the Rab4b compartment in
adipocyte.We established cell lines overexpressing green fluorescent
protein (GFP)-Rab4b at a low level, where we verified that the
fusion protein GFP-Rab4b behave similarly than HA-Rab4b (data
not shown). This low expression level of GFP-Rab4b (less than 2
fold, supplementary Figure S1) did not allow for the direct detection
of the GFP by fluorescence microscopy but requires the use of anti-
GFP antibodies in all the following experiments. We first compared
the subcellular distribution of GFP-Rab4b with GLUT4 and with
VAMP2 (vesicle-associated membrane protein 2), a marker of the
GLUT4 sequestration compartment [1]. In 3T3-L1 adipocytes,
GFP-Rab4b was enriched in a perinuclear region and associated
withsmallvesiclesthroughoutthecytoplasm(Figure4).GFP-Rab4b
was highly co-localized with endogenous GLUT4 in those two
compartments, with an index of 80%. On a similar fashion, most of
GFP-Rab4b was present in structures that contain endogenous
VAMP2 (Figure 5) and around 65% of the two proteins were
Rab4b and GLUT4 in Adipocyte
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5257Figure 1. Expression of Rab proteins in adipose tissue of diabetic subjects. A. Total RNAs were prepared from epididymal adipose tissue of
5 db/+ and 5 db/db mice. The expression levels of mRNA were analyzed by real-time quantitative PCR, normalized to the level of 36B4 mRNA and
expressed in arbitrary units with the control values taken as 1. B. Total homogenates were prepared from epididymal adipose tissue of db/+ and db/
db mice. 40 mg of proteins were separated by SDS-PAGE and transferred to PVDF membranes, which were probed with the indicated antibodies. The
graph represents the quantification of the amount of Rab4, Rab11 and GLUT4 in 6 db/+ and db/db mice. C. Total RNAs were prepared from
subcutaneous adipose tissue of 5 control subjects and 5 severely obese diabetic patients. The mRNA levels were analyzed by real-time PCR,
normalized to the level of RPLP0 mRNA and expressed in arbitrary units as in panel A. Significant with *p,0.05 and
#p,0.01 (Kruskal-Wallis test).
doi:10.1371/journal.pone.0005257.g001
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between GFP-Rab4b and the transferrin receptor (TfR), a marker
of early sorting/recycling endosomes did not overcome 50%
(Figure 6A–C), which is similar to the colocalization extent
described between GLUT4 and TfR [1]. In another adipocyte cell
line that overexpressed GFP-Rab4b by nearly 6 fold, we also
observed that the extent of colocalization of Rab4b is higher with
GLUT4 than with Tfr (Figure S1). In adipocytes that transiently co-
expressed GFP-Rab4b and GLUT4, the two proteins were also
mainly co-localized whereas it is not the case with GFP-Rab4a
(Figure S1).These observationsindicate that Rab4b is presentinthe
compartments where GLUT4 is mainly localized in basal condition
i.e its sequestration compartment and also in TfR containing
endosomes. In accordance with the low colocalization of Rab4a
with Rab4b in adipocytes, we did find a higher colocalization index
between Rab4a and Tfr than between Rab4a and GLUT4
(Figure 6D, and supplementary Figures S2, S3).
Effects of the down-regulation of Rab4b on glucose
uptake
To determine the effect of Rab4b on glucose uptake, we
performed its siRNA-mediated knockdown in 3T3-L1 adipocytes.
Figure 7A shows that 200 nM of the siRNA against Rab4b-1 was
required to inhibit by 60% the expression of Rab4b mRNA.
Inhibition of the Rab4b protein expression was revealed by using
the antiserum we have produced against the C terminal part of
Rab4b (Insert Figure 7A) and its extent reached 53.4%61.2
(n=5). The siRNA Rab4b-1 did not affect the expression of
Figure 2. Characterization of Rab4a and Rab4b expression in adipocytes. A. Northern Blot. mRNA from 3T3-L1 adipocytes, isolated
mouse adipocytes, heart and lung were analyzed by Northern blot with probes specific for Rab4a or Rab4b. B. Rab4b is the major Rab4 member
expressed in adipocytes. RNA was prepared from the indicated cell types. Rab4b and Rab4a gene expression was quantified by real time PCR. The
mRNA amounts were calculated by comparison with the control gene expression and the value 1 was given arbitrary to Rab4a mRNA expression.
Results were expressed as the mean6SEM of 3 different experiments. Significant differences versus Rab4a expression with p value* ,0.05 or
# ,0.01.
C. Rab4b and Rab4a mRNA expression is increased during adipocyte differentiation. The amount of mRNA for Rab4a and Rab4b was
quantified as described in the Materials and Methods section in 3T3-L1 and human preadipocytes and adipocytes. The graph represents the
mean6SEM of 3 different experiments of cell differentiation. The results are expressed as the fold increase in adipocytes versus preadipocytes (taken
as 1) for the two Rab4 members. Statistical differences between adipocytes and preadipocytes with p value *,0.05 and
#,0.01. D. Antibodies
produced against Rab4a also recognized Rab4b. Cells were transiently transfected with a mock vector, pEGF-Rab4a, or pEGFP-Rab4b and
homogenized. Proteins (40 mg were separated by SDS-PAGE, transferred to PVDF membrane, and probed with anti GFP antibodies, anti Rab4a mAb
(BD Biosciences), or anti Rab4a polyclonal [12] antibodies. E. Antibodies produced against Rab4b specifically recognized overexpressed
Rab4b. Cells were transiently transfected as in D and proteins were probed with anti GFP antibodies, or polyclonal anti Rab4b antiserum (see
Material and Methods).
doi:10.1371/journal.pone.0005257.g002
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directed against different Rab4b regions (Table S1) were also able
to inhibit Rab4b expression (Figure 7A) but not Rab4a mRNA
expression (data not shown). The decreased expression of Rab4b
through the use of these three different siRNA caused an increase
in the ability of adipocyte to transport DOG in basal (25%) and
insulin conditions (40%), either at low or maximally stimulating
concentrations (Figure 7B). The effect of insulin is thus not affected
by the down regulation of Rab4b expression. The down-regulation
of Rab4a up to 80% by using two different siRNA did not induce
significant changes in basal or in insulin-induced glucose uptake
(Figure S4). The down regulation of Rab4b expression induced
Figure 3. Rab4a and Rab4b are colocalized in 3T3-L1 fibroblasts, but not in adipocytes. 3T3-L1 fibroblasts and adipocytes transiently
expressing myc-Rab4a and HA-Rab4b were serum deprived and processed for immunofluorescence. Myc-Rab4a is detected with anti myc mAb and
FITC-coupled secondary antibodies. HA-Rab4b is detected with anti HA polyclonal antibodies and TexasRed-coupled secondary antibodies. A
confocal section of the double-transfected cell, and the corresponding enlarged views of the delineated areas are shown. Each labeling (green and
red) as well as the merge images are shown. Cells with comparable levels of fluorescence were chosen. Bar is 1 mm.
doi:10.1371/journal.pone.0005257.g003
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GLUT4 and GLUT1 (figure 7C), the glucose transporters
responsive for glucose transport in 3T3-L1 adipocyte [26]. It did
not affect either insulin-stimulated phosphorylation of the insulin
receptors, IRS, PKB, AS160, or ERK (Figure 7D and Figure S5
for quantifications).
Effects of the down-regulation of Rab4b on GLUT4
localization
We thus aimed at determining whether a redistribution of
GLUT4 at the plasma membrane could explain the stimulatory
effect of Rab4b down regulation on glucose uptake. By using three
experimental approaches we found that the down regulation of
Rab4b expression was accompanied by a change in GLUT4
subcellular location towards the plasma membrane. First, we
observed in basal conditions an increased number of adipocytes
with a GLUT4 rim, a characteristic image of adipocyte with
plasma membrane GLUT4 (Figure 8A). Interestingly, the down
regulation of Rab4a did not induce obvious GLUT4 subcellular
distribution modifications (Figure S4). Second, the GLUT4
immunoreactivity increased in plasma membrane lawns prepared
from basal and insulin-stimulated adipocytes (Figure 8B), without
any concomitant modification of the plasma membrane content of
TfR (Figure 8C). Third, using a technique to render insoluble
(ablated) intracellular compartments containing the TfR by means
of a transferrin-horse radish peroxidase conjugate (Tf-HRP) [27],
we observed that the efficiency of endosomal ablation is modified
for GLUT4 but not for TfR. Endosomal ablation (condition with
Figure 4. Rab4b is associated to the GLUT4 containing compartments. Adipocytes stably expressing GFP-Rab4b were serum deprived
overnight before being processed for immunofluorescence. GFP-Rab4b is detected using anti GFP mAb followed by FITC- coupled secondary
antibodies whereas GLUT4 is detected by goat anti GLUT4 and TexasRed-coupled secondary antibodies. Two confocal sections of the same cell,
obtained in the middle and at the bottom, are shown for the two fluorochromes or merge by using Adobe Photoshop software. Enlarged views of
the delineated areas are in the right column. Colocalization of the two proteins results in a yellow color. Colocalization was also visualized by using
the ImageJ colocalization finder pluging. Pixels over a fixed threshold where a green and red fluorescence were depicted with a ratio 1/1 are shown
in white on the merge image. Bar is 1 mm.
doi:10.1371/journal.pone.0005257.g004
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whole adipocyte homogenates of control cells, compared with a
25% reduction in anti Rab4b siRNA treated cells (Figure 9A), thus
confirming that GLUT4 localization in basal condition was
modified when Rab4b expression is decreased. Furthermore, we
observed that the binding of anti myc antibodies on intact insulin-
treated adipocytes increased following Rab4b down-regulation in
an adipocyte cell line expressing a myc tagged GLUT4-DsRed, a
glucose transporter with an extracellular myc eptitope (Figure 9B).
The increase in glucose transport following insulin treatment
observed in anti Rab4b siRNA-treated adipocytes could thus also
be explained by an increase in GLUT4 at the plasma membrane.
The increase in the amount of GLUT4 at the plasma
membrane could result either from an increase in its exocytosis
or an inhibition of its endocytosis. We thus determined whether
the down regulation of Rab4b could modify GLUT4 internaliza-
tion (Figure 9B). We observed that internalization of extracellu-
larly myc tagged-GLUT4-DsRed was similar in cells transfected
with control or anti Rab4b siRNA, thus strongly suggesting that
inhibition of Rab4b expression favours GLUT4 exocytosis.
In whole cell homogenates, proteins insensitive to endosomal
ablation could be located at the plasma membrane and/or in a
non endosomal intracellular compartment (see [28]). Further, an
increase in GLUT4 amount at the plasma membrane in absence
and in presence of insulin could result from a redistribution of
GLUT4 from its sequestration compartments toward the endo-
somes [29]. We thus wanted to determine whether such GLUT4
redistribution could explain the effect of Rab4b downregulation on
basal and insulin-stimulated glucose transport. We thus needed to
estimate the amount of GLUT4 in endosomal and non-endosomal
compartments. For that, adipocytes treated or not with anti Rab4b
siRNA were processed for Tf-induced endosomal ablation and
enriched-intracellular vesicles were prepared and analyzed for TfR
and GLUT4 content (Figure 9C). In agreement with previous
reports [27,28], 80% of intracellular TfR containing vesicles were
ablated (condition with H2O2) whatever Rab4b was present or
down-regulated. The results differed totally for GLUT4. First,
Rab4b down regulation decreased the intracellular amount of
GLUT4 (condition without H2O2), which confirms our previous
series of observations i.e. an increase of GLUT4 at the plasma
membrane. Second, very few of these vesicles were sensitive to
ablation (condition with H2O2). Because the total GLUT4 amount
was unchanged in lysates, the results suggest that in normal
condition nearly half of intracellular GLUT4 were outside the TfR
containing endosomes and, more importantly, that GLUT4
appears to be mainly excluded from endosomes when Rab4b is
down regulated.
Discussion
Rab proteins are main players of intracellular vesicular traffic
because they control the transport of vesicles between two adjacent
organelles [6]. The identification of Rab proteins associated with
the GLUT4 sequestration compartments represents a major
challenge to understand the GLUT4 recycling pathway. Several
Rabs including Rab2A, Rab4, Rab8A, Rab10, Rab11, and Rab14
have been identified as proteins of immunopurified GLUT4-
containing structures [7,12,15,30,31,32] using methods that do not
discriminate between the various GLUT4-containing intracellular
organelles. It is thus not surprising that a large number of Rabs has
been found associated with GLUT4, because GLUT4 traffics
through numerous organelles on top of its sequestration
compartment [1].
The method of choice to determine which Rabs localize in
GLUT4 sequestration compartment is thus indirect immufluores-
cence using confocal microscopy. The lack of antibodies
recognizing endogenous Rab in immunofluorescence has likely
restrained such studies, and only one describes a small colocaliza-
tion of Rab14 with GLUT4 positive vesicles [32]. The Rab
proteins specifically associated with the GLUT4-sequestration
compartments thus remain to be identified and our results strongly
suggest that Rab4b is one of them. Indeed, we found Rab4b
widely located with GLUT4, thus indicating that under basal
condition Rab4b localized in most of the numerous GLUT4
compartments, including the GLUT4-sequestration one. In
accordance, the majority of VAMP2-containing structures, known
Figure 5. Rab4b is present in the VAMP2-containing compart-
ment. In cells obtained as described in Figure 4, GFP-Rab4b is detected
by anti GFP rabbit polyclonal antibodies and FITC-coupled secondary
antibodies. VAMP2 is detected by mAb followed by TexasRed-coupled
secondary antibodies. One middle confocal section is shown. Enlarged
views of the square delineated with continuous lines are shown in the
right panels. Colocalisation was also visualized by using the ImageJ
colocalization finder pluging. Bar is 1 mm.
doi:10.1371/journal.pone.0005257.g005
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PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5257Figure 6. GFP-Rab4b is partially colocalized with TfR. GFP-Rab4b expressing cells were obtained as in figure 4. TfR is detected by mAb
followed by TexasRed-coupled secondary antibodies. Confocal sections obtained in the bottom (A) and one in the middle (B) of an adipocyte are
shown. Enlarged views of the delineated areas are in the right columns. Each labeling (green and red) as well as the merge images are shown. Bar is
1 mm. Colocalization was also visualized by using the ImageJ colocalization finder pluging. C. The quantification of the colocalization between GFP-
Rab4b and the indicated proteins (corresponding to figures 4–6) was performed by using the image correlator plus function of ImageJ. The index of
colocalization corresponds to the mean of the overlap coefficient (R)*100 obtained for more than 20 cells for each co-labeling. The ratio between
green and red signals is comprised between 0.8 and 1.2. *indicates a significant difference in the index of Rab4b colocalization with VAMP2 compared
with GLUT4, whereas
# indicates a significant difference in the index of Rab4b colocalization with TfR compared with VAMP2, the two p being ,0.01
(Kruskal-Wallis test).
doi:10.1371/journal.pone.0005257.g006
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labelled by Rab4b. Rab4b is thus the first Rab of these specialized
compartments, but it is also found in TfR-containing endosomes.
This endosomal localization in adipocytes could explain why
Rab4b is mainly colocalized with the endosomal marker Rab4a in
fibroblasts and not in adipocytes. Indeed, the GLUT4 sequestra-
tion compartment is absent in fibroblast and is formed along the
adipocyte differentiation process [33]. Our data concerning
Rab4b localization are strengthened by the fact that the extent
of colocalisation between Rab4a and GLUT4 is low, whereas
Rab4a is essentially colocalized with TfR. To circumvent the lack
of antibodies able to detect endogenous Rab4b by immunofluo-
rescence, we used the GFP-tag as the Rab location reporter. This
fusion protein is predicted to have similar functions and thus the
same location as the wild type Rab4b. Indeed, N-terminal GFP
fusion with Rab proteins does not affect their functionality [34]
and GFP-Rab4b co-localized with the Rab4b fused with a smaller
tag (HA-Rab4b). We used a retrovirus infection in order to obtain
a low level of exogenous Rab4b expression unlikely to impair their
localization and organelle morphology (less than 2 fold). We
further observed that a higher expression of GFP-Rab4b did not
impair its extent of colocalization with GLUT4.
Figure 7. Effect of the downregulation of Rab4b on deoxyglucose uptake in adipocytes. A. 3T3-L1 adipocytes were transiently
transfected with control siRNA or the three siRNA against Rab4b at the indicated concentration. 48 h later, the amount of Rab4b mRNA was
quantified by using real-time PCR. Graph represents the relative mRNA levels for Rab4b in cells treated with Rab4b siRNA compared with cells treated
with the corresponding concentration of control siRNA. No differences in Rab4b mRNA expression were observed with the two concentrations of
control siRNA, or with cells treated without siRNA or with INTERFERin
TM alone. In the inset is shown the immunodetection of Rab4b, and tubulin as a
loading control, of adipocyte homogenates treated with control or anti Rab4b-1 siRNA and prepared 72h after the transfection. B. Cells were
transiently transfected with 200 nM of control siRNA or of the three siRNA against Rab4b. 72 h later, cells were serum deprived for 2 h, then treated
or not with the indicated concentrations of insulin, before measurement of deoxyglucose uptake, as described in Methods. The figure represents the
mean6SEM of 4–6 experiments. * indicated results that are statistically significant compared with control siRNA-treated cells using paired student t
test (p,0.005). C. Adipocytes were transfected as in A with 200 nM of the indicated siRNA and total homogenates were prepared 72 h later. 40 mgo f
proteins were resolved by SDS-PAGE. GLUT4, GLUT1, and tubulin as a loading control were then detected by immunodetection. D. 3T3-L1 adipocytes
were transfected with the indicated siRNA. 72 h later, they were serum deprived for 2 h, then treated without or with the indicated concentrations of
insulin for 10 min. Total homogenates were prepared and 40 mg of protein were resolved by SDS-PAGE. Tyrosine phosphorylated proteins,
phosphorylated PKB, AS160, total PKB and tubulin were revealed by using specific antibodies. Asterisks indicates phosphorylated insulin receptor and
its substrates IRS.
doi:10.1371/journal.pone.0005257.g007
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PLoS ONE | www.plosone.org 9 April 2009 | Volume 4 | Issue 4 | e5257Figure 8. A decreased expression of Rab4b increased GLUT4 localization at the plasma membrane. A. Cells were transiently transfected
with 200 nM of control siRNA or of the indicated siRNA against Rab4b. 72 h later, cells were serum deprived for 2 h and processed for endogenous
GLUT4 immunodetection. Typical fields and a 3D reconstruction of one adipocyte performed with the Volocity software are shown as well as the
quantification of the number of adipocytes with peripheral labeling (rim) of GLUT4 (bar 10 mm). About 100 cells were examined in at least 10 different
fields for each condition. The experiment was reproduced 3 fold and the figure shows the mean6SEM of these experiments. * indicates that the
differences were significant with p,0.001 using the Kruskal-Wallis test relative to control siRNA-treated cells. B.C. Adipocytes were transiently
transfected with 200 nM of control or anti Rab4b-1 siRNA. 72 h later, cells were serum deprived, treated with the indicated concentration of insulin,
and used to prepare plasma membrane lawns. GLUT4 and Tfr were detected by indirect immunofluorescence in B and C, respectively. Representative
fields were shown and the quantification of the amount of GLUT4 or TfR was performed as indicated in the Material and Methods section. The
differences between control and siRNA treated cells are significant with p,0.01* and p,0.001 (Kruskal-Wallis test).
doi:10.1371/journal.pone.0005257.g008
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GLUT4 sequestration compartment, it could play a role in its
traffic between these two compartments. If such is the case, the
inhibition of Rab4b function should interfere with GLUT4
recycling and probably with insulin-induced glucose transport.
Decreasing the expression levels of Rab4b mRNA by 60% yields
to a small increase in basal glucose uptake and a more sustained
effect at a physiological and maximal concentration of insulin. The
insulin effect remained similar in control and anti Rab4b siRNA
treated adipocytes. The down regulation of Rab4a expression, by
contrast, did not changed basal nor insulin-induced glucose
transport. However, previous studies using overexpression of
Rab4a [12] or of the Rab4a effector Rabip4 led to the conclusion
that Rab4a was involved in GLUT4 trafficking [22]. One
explanation could be that Rab4b could fulfil Rab4a function in
its absence. It should also be kept in mind that Rab4a is weakly
expressed compared to Rab4b in adipocyte. Further, Rabip4 is an
effector of both Rab4a and Rab4b [35].
This increase in glucose uptake observed with Rab4b siRNA
treatment could be explained by the presence of more GLUT4
molecules at the plasma membrane, as evidenced by multiple
experimental approaches. Our results indicate that decreasing the
amount of Rab4b perturbs the location of GLUT4, but not that of
TfR. Rab4b would thus act on a trafficking step which does not
involve the classical endosomal recycling, but specifically concerns
the GLUT4-sequestration compartment. Furthermore, the in-
crease in plasma membrane GLUT4 in basal condition does not
appear to result from a decrease in GLUT4 endocytosis or from a
transfer of GLUT4 towards the endocytic compartments, as
indicated by the Tf-HRP induced endosomal ablation. This would
be indeed predicted from recent results showing that an increase in
GLUT4 amount at the plasma membrane in basal and insulin
conditions could be due to a redistribution of GLUT4 from its
sequestration compartment to the endosomes [29]. Thus, a
possible mechanism could be that Rab4b is involved in the
intracellular retention machinery of GLUT4 both in basal and in
insulin-stimulated conditions. Rab4b could be involved in a
GLUT4 cycle between the sequestration compartment and plasma
membrane or/and between the sequestration compartment and
other intracellular organelles, as schematized in figure 10. The
function of Rab4b seems however to differ from that of Rab31.
Indeed, Rab31 knock-down does not favour plasma membrane
GLUT4 localization in basal condition. Furthermore, Rab31
potentiates insulin action [18], whereas the efficiency of insulin to
recruit GLUT4 at the plasma membrane is unaffected by the
inhibition of Rab4b expression. Rab4b function also differs from
that of Rab4a. Indeed, in absence of coupling of Rab4a with its
effector Rabip4, GLUT4 traffic between endosomes and the
sequestration compartment is altered [22]. When Rab4b expres-
sion is decreased, intracellular GLUT4 is mainly in its sequestra-
tion compartment thus suggesting that trafficking between
endosomes and the sequestration compartment occurs. The next
steps will be to determine the exact trafficking event(s) controlled
by Rab4b. The challenge will be to develop new experimental
strategies to invalidate more efficiently Rab4b and to characterize
specific Rab4b effectors in adipocytes.
A consistent down-regulation of Rab4b mRNA expression in
adipose tissues of severely obese and diabetic patients and animals
was observed. According to our in vitro results, this decrease could
Figure 9. Effect of a decreased Rab4b expression on GLUT4
location by using Tf-HRP-induced endosomal ablation. A. 3T3-
L1 adipocytes were transiently transfected with 200 nM of control or
anti Rab4b-1 siRNA. 72 h later, cells were serum deprived and treated as
indicated in the Material and Methods section for the ablation of
endosomes. Total homogenates were prepared from 3T3-L1 adipocytes
loaded with Tf-HRP for 2 h at 37uC without or with performing the
ablation of the endosomes (minus and plus H2O2, respectively).
Representative immunoblots for GLUT4, TfR, and tubulin as a loading
control not affected by the endosomes ablation, were shown, as well as
the quantification of 3 independent experiments. An aliquot of total
lysate from cells treated with control or anti Rab4b-1 siRNA was also
analyzed to determine the effect of Rab4b downregulation on the
expression level of GLUT4 and TfR. B. 3T3-L1 adipocytes stably
expressing myc tagged-GLUT4-DsRed were transiently transfected with
200 nM of control or anti Rab4b-1 siRNA. 72 h later they were treated
for an internalization assay as described in the Materials and Methods
section. The inset shows the amount of GLUT4-myc-DsRed inserted
within the plasma membrane following insulin stimulation. The graph
represents the GLUT4-myc-DsRed at the plasma membrane at various
periods of time following the induction of internalization processes
expressed as the % of the amount detected at time 0. The results are
expressed as the mean6SE of two independent experiments. C.
Adipocytes were treated as in A and intracellular vesicles were prepared
as described in the Material and Methods section. Representative
immunoblots for GLUT4, TfR, and tubulin as a loading control, were
shown, as well as the quantification of 3 independent experiments. An
aliquot of total lysate from cells treated with control or anti Rab4b-1
siRNA was also analyzed to determine the effect of Rab4b downreg-
ulation on the expression level of GLUT4 and TfR.
doi:10.1371/journal.pone.0005257.g009
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However, these observations are paradoxical because a decreased
Rab4b expression positively regulates insulin-induced glucose
transport in cell systems whereas insulin-induced glucose transport
is altered in adipose tissue from obese subjects. Although not
testable, this decrease could contribute to fight adipocyte insulin
resistance by increasing resting glucose uptake in order to
compensate the decreased adipocyte GLUT4 expression, a
common feature of many insulin resistant states [36] that we also
observed in our partients. Presently, there is no proof that the
proportion of plasma membrane GLUT4 is increased in insulin
resistant situations although it has been suggested in two studies
[4,37]. Indeed, it was shown that the plasma membrane content of
IRAP, which recycles like GLUT4 in adipocytes and has an
unaltered expression, is increased in plasma membranes of
adipocytes isolated from diabetic patients [4]. Changes in
intracellular GLUT4 and/or IRAP location between control and
diabetic patients were also evidenced in adipocyte and muscle by
using fractionation procedures [3,4,5]. Further studies will be
needed to characterize the subcellular distribution of GLUT4 and
IRAP in insulin resistant situations. Altogether, our results
documents Rab4b as the first Rab protein which co-localize in
adipocytes with GLUT4 in its sequestration compartments which
is modulated in diabetes.
Materials and Methods
Antibodies
Goat polyclonal antibodies against GLUT 4 and anti myc
epitope mAb (9E10) were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Anti VAMP2 and GFP mAb was from Synaptic
Systems (Go ¨ttingen, Germany). Rabbit polyclonal antibodies
against GFP were from BD Biosciences Clontech (Palo Alto,
CA, USA). Anti Rab4 mAb was from BD Biosciences Pharmingen
(San Diego, CA, USA). Anti transferrin receptor (TfR) monoclonal
antibodies (mAb) and anti Rab11 polyclonal antibodies were from
Zymed Laboratories Inc (San Fransisco, CA, USA). Rabbit
polyclonal against GLUT1 was from Abcam (Cambridge, UK).
Antibodies against Phospho-PKB (Thr308) and PKB were from
Cell Signalling (Beverly, MA, USA). Antibodies against Phospho-
AS160 were from Biosource (Camarillo, CA, USA). Anti tubulin
mAb was from Sigma (Saint Louis, MO, USA). Rabbit polyclonal
antibodies against Rab4a were produced as described in [12].
Horseradish peroxidase-conjugated and fluorochrome conjugated
secondary anti species antibodies were from JacksonImmunoR-
esearch Laboratories, Inc (West Grov, PA, USA). TrueBlotTM
ULTRA HRP anti mouse IgG was from eBioscience (San Diego,
CA, USA). Antibodies against Rab4b were obtained by immu-
nizing rabbits with a 12 amino acids peptide corresponding to the
C terminal part of Rab4b coupled to KLH (Eurogentec, Seraing,
Belgium).
Reagents
DNA modifying enzymes were from NEW ENGLAND Biolabs,
Inc (Beverly, MA, USA), chemicals from Sigma (St. Louis, MO,
USA). SYBR green were Eurogentec (Seraing, Belgium), kits for
DNA purification from Qiagen (Valencia, CA), cell culture media
from Invitrogen (Carlsbad, CA). Oligonucleotides were synthe-
tized by Eurogentec (Seraing, Belgium) and their sequences are
available upon request. We used the large P0 subunit of the acidic
ribosomal phosphoprotein-RPLP0 as an invariant control [38,39].
We also used TaqMan primers for human Rab4a and Rab4b
(Applied Biosystem). A siRNA against mouse Rab4b was designed
and synthetized by Eurogentec (siRNA-Rab4b-1, Seraing, Bel-
gium). siRNA-Rab4b-2 is from Dharmacon. siRNA-Rab4b-3 is
from Ambion (Austin TX, USA). Their sequences were provided
in supplementary Table S1. Control siRNA was from Eurogentec.
HRP-conjugated mouse transferrin was from JacksonImmunoR-
esearch Laboratories, Inc (West Grov, PA, USA).
cDNAs and Plasmids
Mouse Rab4b cDNA is the RIKEN clone AK005314. The
coding sequence of Rab4b was amplified by PCR and subcloned
into pEGFP-C1 (BD Biosciences Clontech) to obtain a N-terminal
GFP fusion protein. The sequence encoding GFP-Rab4b, GFP-
Rab4a [40], and GLUT4-myc-DsRed [22] were subcloned into
Figure 10. Schematic representation of the putative role of Rab4b in GLUT4 trafficking control. TfR (transferrin receptor in orange) and
GLUT4 (in green) continuously recycle between intracellular compartments and the plasma membrane. However their routes are divergent. TfR only
used the early endosomes (sorting and recycling ones) as intracellular reservoir whereas GLUT4 is also found in the trans Golgi network and in the
GLUT4 sequestration vesicles (GSV). Because down regulation of Rab4b affects GLUT4 location, but not that of TfR, it is suspected to play a role in
GLUT4 specific trafficking step(s). Its role would be to retain GLUT4 intracellularly by controlling positively or negatively one or more steps of
trafficking involved in these retention loops.
doi:10.1371/journal.pone.0005257.g010
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puro, allowing for the production of
retrovirus used to infect 3T3-L1 fibroblasts. The amplified Rab4b
coding sequence was sub-cloned in pcDNA3-HA (Invitrogen,
Carlsbad, CA) to obtain N-terminal HA tagged Rab4b. Other
Rab4a constructions used were described in [41].
Animals
Fed db/+ and db/db male mice (C57BL/KSJ-mLep
db/+ or
mLep
db/mLep
db), obtained from Janvier (Le Genest St Isle, France)
were studied at 13 weeks of age. Fed glycemia were measured
using a blood glucose meter and were 31.660.72 and
10.060.3 mM in db/db and db/+ mice, respectively (mean6SEM
of 5 mice). Animal experimentation was conducted in agreement
with accepted standards of animal care. The experiment protocol
has been reviewed and accepted by our Institutional Ethic Animal
Care Committee.
Human subcutaneous adipose tissue biopsies
Five morbidly obese diabetic women (age 4969 years, BMI
4467 kg/m
2, fasted glycemia 11.763 mM, HbA1c, 962%) were
recruited while they were selected for a bariatric surgery. Lean
women (3) and men (2) (age 40612 years, BMI 2161 kg/m
2,
fasted glycemia 4.961 mM) were recruited while undergoing
inguinal hernia, pancreatitis surgery, or lipectomy. The study was
performed according to the French Huriet-Serusclat law, with the
acceptance of a National Board under the agreement number
DGS 2003/0395. Informed written consent was obtained from all
subjects. During surgery, surgical subcutaneous adipose tissue
biopsies were obtained and immediately frozen in liquid nitrogen
and stored at 280uC.
Cells
3T3-L1 cells were cultured and differentiated into adipocytes as
described [22]. To establish 3T3-L1 cell lines stably expressing
GFP-Rab4b, 3T3-L1 fibroblasts were infected with the adequate
retrovirus, selected in puromycin (2 mg/ml), and differentiated into
adipocytes. This procedure allows for low levels of protein
overexpression in nearly all the cells. Transfection of siRNA was
performed by using INTERFERin
TM according to the manufac-
turer’s instructions (Ozyme). Human preadipocytes from lean non
diabetic subjects (Biopredic, Rennes, France) were grown,
differentiated into adipocytes, and used 10–15 days later as
described [42].
Real-time PCR
RNAs were prepared using the RNeasy total RNA kit (Qiagen,
France), treated with DNAse (Ambion Inc), and used to synthetize
cDNAs with cDNA High Capacity Archive Kit (Applied
Biosystems). Real-time quantitative RT-PCR was performed with
the ABI PRISM 7000 sequence Detection System (Applied
Biosystems) and SYBR green dye or TaqMan technology [39].
The mRNA levels (R) were expressed relative to levels of the large
P0 subunit of the acidic ribosomal phosphoprotein-RPLP0 (named
36B4 in mice) (DCt=CtR-CtRPLP0). The relative amount of
mRNA between two groups is given by 2
2DDCt, where
DDCt=[DCt(R) of obese or diabetic patient]-[mean of DCt(R)
of lean group]. Statistical significance was determined using the
non-parametric Kruskal-Wallis test with the DCt of the different
groups. p,0.05 was significant.
Immunofluorescence
Cells on glass coverslips were analyzed by sequential scanning
confocal fluorescent microscopy with a PL APO 6361.4 oil
objective (TSP SP, Leica, Deerfield, IL, USA or LSM 510, Zeiss,
Go ¨ttingen, Germany [22,40]. The images were combined by using
PhotoShop (Mountain View, CA, USA) and analyzed with the
ImageJ software. Image acquisition and analyzis were performed
on the C3M MicorBio Cell Imaging Facility.
Quantification of GLUT4 and TfR present at the plasma
membrane
3T3-L1 cells were grown on glass coverslips, differentiated into
adipocytes, and stimulated or not with insulin for 20 min. Plasma
membrane sheets were prepared, immuno-stained with anti
GLUT4 or anti TfR antibodies, and quantification of their
amount was performed as previously described in [22,43] using
WGA labeling for normalization to the amount of membranes.
Glucose Transport
3T3-L1 adipocytes were serum deprived for 2 h, treated
without or with the indicated concentrations of insulin. Glucose
transport was determined by adding 2-[
3H]deoxyglucose
(0.1 mM, 0.5 mCi/ml) for 3 min [22,42]. Cells were washed four
times with ice-cold PBS, lysed and used to assess glucose uptake by
scintillation counting. Results were normalized for protein content.
GLUT4 internalization assay
Adipocytes stably expressing GLUT4myc-DsRed cells were
serum deprived before a treatment with 10 nM insulin to trigger
GLUT4myc-DsRed at the plasma membrane. Cells were then
incubated with anti myc antibodies (25 mg/ml) for 2 h at 4uCi n
DMEM containing 20 mM Hepes, pH 7.4 and 1% BSA. At the
end of this incubation, cells were washed 6 times with ice cold
DMEM/Hepes/BSA and then wortmannin (100 nM) was added to
inhibit insulin signaling without affecting GLUT4 internalization
[44]. Cells were then transferred at 37uC to trigger the
internalization of GLUT4, and at different times, paraformalde-
hyde was added to a concentration of 4%. After 5 min, the
paraformaldehyde was quenched with NH4Cl. Cells were washed 3
times with PBS and then incubated for 1 h at room temperature
with 0.1 mg/ml of HRP-coupled anti mouse antibodies in DMEM/
Hepes/BSA. Antibodies only recognized plasma membrane
GLUT4. Adipocytes were extensively washed before the quantifi-
cation of the amount of HRP-coupled anti mouse antibodies by
using o-phenylenediamine dihydrochloride as substrate (reference
P-9187, Sigma, St Louis, MO, USA). Non specific binding,
determined by identically treating adipocytes that did not express
GLUT4-myc-DsRed was subtracted from all the values.
Endosomal ablation through the use of HRP-conjugated
transferrin (HRP-Tf)
The endosomal ablation was performed according to Melvin et
al [45]. 3T3-L1 adipocytes were serum deprived for 2 h before
starting an incubation of 2 h with 20 mg/ml of HRP-Tf at 37uC.
To eliminate surface-bound HRP-Tf, cells were washed 3 times
for 10 min with ice-cold isotonic citrate buffer (150 mM NaCl and
20 mM sodium citrate (pH 5.0). Cells were then washed in ice-
cold PBS. Diamino benzidine (DAB) was added (100 mg/ml) to all
cells, and H2O2 was added (0.04%) to one of each pair of wells.
After incubation for 1 h at 4uC in the dark, the reaction was
stopped by washing in ice-cold PBS containing 5% BSA. Cells
were then extensively washed with ice cold PBS, resuspended in
Tris pH 7.4 containing 250 mM sucrose and a cocktail of protease
inhibitor (completeTM, Roche Diagnostics, Manheim, Germany).
After homogenisation by 10 passages through a 22G needle, cells
were centrifuged 10 min at 5 000 g at 4uC to eliminate non-
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pared for protein analysis or subjected to a 30 min centrifugation
at 19 000 g and 4uC to eliminate plasma membranes. Superna-
tants (intracellular vesicles) were prepared for analysis of the
GLUT4, TfR, and tubulin content by Western Blot. Detection of
the proteins was made by chemiluminescence with a FUJIFILM
LAS-3000 (FUJIFILM France S.A.S, St Quentin en Yvelines,
France).
Supporting Information
Table S1 Sequences of the siRNA used against RAb4a and
Rab4b. The sequence of the forward siRNA are given as well as
their position relative to the sequence of Rab4a or RAb4b mRNA.
All siRNAs targeted the coding sequences thus decreasing the
possible side effects linked to miRNA mimicking.
Found at: doi:10.1371/journal.pone.0005257.s001 (0.03 MB
DOC)
Figure S1 Localization of GFP-Rab4b in a second adipocyte cell
line. A. The levels of overexpression of GFP-Rab4b were
determined in two independent 3T3-L1 cell lines at the adipocyte
stage. The cell line GFP-Rab4b#1 was used in Figures 4–6. The
amount of GFP-Rab4b was determined by using an anti GFP. The
numbers indicates the quantification of the bands corresponding to
GFP-Rab4b normalized by that of tubulin. The amount of Rab4b
mRNA (Rab4b+GFP-Rab4b) was determined in each cell line as
in the wild type one (wt) by using real time PCR and specific
primers designed in the coding sequence. We verified that the
adipocytes from each cell lines were identically differentiated by
quantifying PPARgamma2, a marker of adipocyte differentiation.
B–C. GFP-Rab4b is associated with GLUT4 containing compart-
ment and is partially colocalized with Tfr in GFP-Rab4b#2
adipocytes. Adipocytes were treated like in Figure 4 and 6. Two
confocal sections, obtained in the middle and at the bottom of the
cells, are shown for GFP-Rab4b (green), GLUT4 (red), and the
merge image. Quantifications of the index of colocalization were
performed as in Figure 6 and were shown in the panel C. *
indicates significant differences with p,0.001 by using the
Kruskal-Wallis test. D. Adipocytes were transiently cotransfected
with vectors encoding for GFP-Rab4b and myc tagged GLUT4-
DsRed and processed for direct fluorescence. E. Adipocytes were
transiently cotransfected with vectors encoding for GFP-RAb4a
and myc tagged GLUT4-DsRed. Bars are 10 mm.
Found at: doi:10.1371/journal.pone.0005257.s002 (2.92 MB TIF)
Figure S2 GFP-Rab4a localization with Glut4. Adipocytes
stably expressing GFP-Rab4a were serum deprived overnight
before being processed for immonufluorescence. GFP-Rab4a is
expressed using anti GFP monoclonal antibody followed like in
Figure 4. Two confocal sections of the same cells, obtained in the
middle and the bottom of the cells, are shown for GFP-Rab4a
(green), GLUT4 (red), and the merge image. Enlarged views of the
delineated areas are shown in the right columns. Bar is 1 mm.
Found at: doi:10.1371/journal.pone.0005257.s003 (2.17 MB TIF)
FigureS3 GFP-Rab4alocalizationwithTfR.Immunofluorescence
of adipocytes expressing GFP-Rab4a were treated as above. GFP-
Rab4a was detected using polyclonal anti GFP whereas Tfr was
detected with a mAb. Two confocal sections of the same cells,
obtained in the middle and the bottom of the cells, are shown for
GFP-Rab4a (green), TfR (red), and the merge image. Enlarged views
of the delineated areas are shown in the right columns. Bar is 1 mm.
Found at: doi:10.1371/journal.pone.0005257.s004 (2.08 MB TIF)
Figure S4 Effect of Rab4a down regulation on glucose uptake
and GLUT4 localization in 3T3-L1 adipocytes. A. Adipocytes
were transiently transfected with 200 nM of control or anti Rab4a
(Sequences provided in supplementary File 2). 72 h later, cells
were processed as in Figure 7 in order to measure DOG uptake. B.
Cells were treated as in A and GLUT4 localization was
determined by indirect immunofluorescence. C. Adipocytes were
transiently transfected with 200 nM of control, anti Rab4b, or anti
Rab4a siRNA. 72 later the amount of Rab4a and Rab4b mRNA
was measured by real time PCR. The results were expressed
relative to the amount of each mRNA in control cells. D.
Adipocytes were transiently transfected with control, anti Rab4a-
1, anti Rab4a-2, or remained untreated (no). 72 h later total
homogenates were prepared and the amount of GLUT4, GLUT1,
Rab4 and tubulin determined by western blotting with their
respective antibodies.
Found at: doi:10.1371/journal.pone.0005257.s005 (1.03 MB TIF)
Figure S5 The down regulation of Rab4b did not alter the
activity of PKB. Adipocytes were transfected with the indicated
siRNA like in Figure 7. 72 h later they were serum deprived and
treated with the indicated concentrations of insulin (like in
figure 7D). 40 mg of proteins were analyzed for phosphorylated
phospho-Thr308 PKB (A) and phosphorylated AS160 (B), as well
as total PKB and AS160 for normalization. The results are
expressed as the % of the maximal effect in control siRNA-treated
adipocytes. The mean +/2 SEM of three experiments was shown.
Found at: doi:10.1371/journal.pone.0005257.s006 (0.09 MB TIF)
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